US › Healthcare

MediciNova Inc (MNOV)

US · Healthcare · Biotechnology

$1.42-2.07%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$458,439

Revenue YoY

+240.6%

Net profit

$-2.3M

EPS

$-0.05

EPS estimate

$-0.06

Net margin

-504.8%

EPS came in at -0.05 against a street estimate of -0.06 — a beat of 16.7%.

Key statistics

Market cap

$73.8M

Forward P/E

8.5

P/B

3.67

Book value

$0.76

EPS (TTM)

$-0.21

52-week high

$3.90

52-week low

$1.17

50-day MA

$1.77

200-day MA

$1.51

Beta

0.61

Analyst view

Analysts rate MediciNova Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $8.25.

Shareholding

Insiders

2.86%

Institutions

20.38%

Largest institutional holders

Fund	Stake
Essex Woodlands Health Ventures	2.25%
BlackRock Inc	1.53%
Citigroup Inc	1.29%
Vanguard Capital Management, LLC	1.24%
Geode Capital Management, LLC	1.10%
Vanguard Fiduciary Trust Co	0.57%
UBS Group AG	0.45%
Renaissance Technologies Corp	0.42%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for MediciNova Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.